Abstract

Pulmonary hypertension and cor pulmonale are complications of severe equine asthma, as a consequence of pulmonary hypoxic vasoconstriction. However, as pulmonary hypertension is only partially reversible by oxygen administration, other etiological factors are likely involved. In human chronic obstructive pulmonary disease, pulmonary artery remodeling contributes to the development of pulmonary hypertension. In rodent models, pulmonary vascular remodeling is present as a consequence of allergic airway inflammation. The present study investigated the presence of remodeling of the pulmonary arteries in severe equine asthma, its distribution throughout the lungs, and its reversibility following long-term antigen avoidance strategies and inhaled corticosteroid administration. Using histomorphometry, the total wall area of pulmonary arteries from different regions of the lungs of asthmatic horses and controls was measured. The smooth muscle mass of pulmonary arteries was also estimated on lung sections stained for α-smooth muscle actin. Reversibility of vascular changes in asthmatic horses was assessed after 1 year of antigen avoidance alone or treatment with inhaled fluticasone. Pulmonary arteries showed increased wall area in apical and caudodorsal lung regions of asthmatic horses in both exacerbation and remission. The pulmonary arteries smooth muscle mass was similarly increased. Both treatments reversed the increase in wall area. However, a trend for normalization of the vascular smooth muscle mass was observed only after treatment with antigen avoidance, but not with fluticasone. In conclusion, severe equine asthma is associated with remodeling of the pulmonary arteries consisting in an increased smooth muscle mass. The resulting narrowing of the artery lumen could enhance hypoxic vasoconstriction, contributing to pulmonary hypertension. In our study population, the antigen avoidance strategy appeared more promising than inhaled corticosteroids in controlling vascular remodeling. However, further studies are needed to support the reversibility of vascular smooth muscle mass remodeling after asthma treatment.

Highlights

  • Severe equine asthma is a chronic, non-infectious inflammatory lower airway disease, characterized by recurrent episodes of airway obstruction induced by exposure to environmental antigens [1,2,3]

  • The wall thickening was not associated with an increase in % of medial area or % of intimal area in asthmatic horses compared to controls (p = 0.46 and p = 0.44, respectively)

  • The present study revealed significant pulmonary artery wall thickening in asthmatic horses compared to controls

Read more

Summary

Introduction

Severe equine asthma ( known as Heaves and Recurrent Airway Obstruction) is a chronic, non-infectious inflammatory lower airway disease, characterized by recurrent episodes of airway obstruction induced by exposure to environmental antigens (including fungi, hay mites and endotoxins) [1,2,3]. Pulmonary hypertension and reversible cor pulmonale are reported as clinical complications of severe equine asthma [4,5,6]. Chronic hypoxia and hypoxemia exacerbate sustained hypoxic pulmonary vasoconstriction, increasing pulmonary vascular resistance and contributing to pulmonary hypertension onset and progression [9]. Airway obstruction was recently shown to induce pulmonary hypertension with right ventricular structural and functional alterations [10]. Their pulmonary artery pressure, measured by invasive right heart catheterization, inversely correlates with arterial oxygen tension, suggesting a significant role of hypoxic pulmonary vasoconstriction in increasing pulmonary vascular resistance and subsequently the mean pulmonary artery pressure [10, 11]. Other factors likely contribute to pulmonary hypertension development onset in asthmatic horses

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.